BNP Antibody (D-8): sc-271185

BNP Antibody (D-8) is a mouse monoclonal IgM antibody that detects BNP protein of human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). BNP (D-8) antibody is available as the non-conjugated anti-BNP monoclonal isotype antibody. BNP, also known as brain natriuretic peptide, plays a crucial role in cardiovascular homeostasis by regulating blood pressure and fluid balance. BNP is primarily secreted by the ventricles of the heart in response to increased wall tension, which often occurs in conditions such as heart failure. BNP release leads to natriuresis, diuresis, and vasodilation, which collectively help to alleviate the burden on the heart and improve hemodynamics. Elevated levels of BNP in the bloodstream serve as a biomarker for heart failure, making anti-BNP antibody (D-8) an essential tool for both research and clinical diagnostics. BNP is part of a family of natriuretic peptides that includes atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP), all of which share a similar structure characterized by a 17-residue ring formed through an intramolecular disulfide bond. BNP and ANP genes are located on human chromosome 1p36.22, while CNP is found on chromosome 2q37.1, highlighting the evolutionary conservation and functional significance of these peptides in cardiovascular physiology.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Contains Mercury: All HRP conjugates (including bundle forms) contain thiomersal, a mercury compound. Do not dispose in trash. Dispose as hazardous chemical waste according to local, state and federal regulations.

Download thiomersal SDS

BNP Antibody (D-8) References:

1. [Proceedings: Systemic-pulmonary arteriovenous fistula--a report of a case].  |  Saito, T., et al. 1975. Jpn Circ J. 39: 723. PMID: 1152210
2. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.  |  Mair, J., et al. 2001. Clin Chem Lab Med. 39: 571-88. PMID: 11522102
3. BNP and congestive heart failure.  |  Cowie, MR. and Mendez, GF. 2002. Prog Cardiovasc Dis. 44: 293-321. PMID: 12007084
4. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations.  |  Hobbs, FD., et al. 2002. BMJ. 324: 1498. PMID: 12077039
5. Essential biochemistry and physiology of (NT-pro)BNP.  |  Hall, C. 2004. Eur J Heart Fail. 6: 257-60. PMID: 14987573
6. Use of NT-proBNP in routine testing and comparison to BNP.  |  Pfister, R., et al. 2004. Eur J Heart Fail. 6: 289-93. PMID: 14987578
7. Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.  |  Lellouche, N., et al. 2007. Am J Cardiol. 99: 242-6. PMID: 17223426
8. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.  |  Sheen, V., et al. 2007. Am Heart J. 153: 244.e1-5. PMID: 17239684
9. Brain-type natriuretic peptide secretion following febrile and afebrile seizures - a new marker in childhood epilepsy?  |  Rauchenzauner, M., et al. 2007. Epilepsia. 48: 101-6. PMID: 17241215
10. Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine.  |  Uzar, E., et al. 2011. Eur Rev Med Pharmacol Sci. 15: 1111-6. PMID: 22165670
11. Brain natriuretic peptide (BNP) may play a major role in risk stratification based on cerebral oxygen saturation by near-infrared spectroscopy in patients undergoing major cardiovascular surgery.  |  Mukaida, H., et al. 2017. PLoS One. 12: e0181154. PMID: 28704502
12. Evaluation of Agonal Cardiac Function for Sudden Cardiac Death in Forensic Medicine with Postmortem Brain Natriuretic Peptide (BNP) and NT-proBNP: A Meta-analysis.  |  Cao, Z., et al. 2020. J Forensic Sci. 65: 686-691. PMID: 31738462

Monoclonal antibodies for mammalian and non-mammalian protein targets represent essentially all targets covered by polyclonal antibodies. Over 8,300 of our antibodies are offered as ImmunoCruz^® conjugates which eliminates the need for a secondary antibody.

Santa Cruz Biotechnology antibodies have over 360,000 research citations. Anti-BNP Antibody (D-8) has 31 citations in a variety of scientific publications.

Primary antibodies like Anti-BNP Antibody (D-8) for mammalian target proteins are recommended for the detection of a range of mammalian species, primarily of mouse, rat and human species. Many mammalian antibodies are also ideal for veterinary research and reactive with ovine, porcine, caprine, feline, canine, bovine and equine protein targets. Santa Cruz Biotechnology primary monoclonal antibodies are suitable for laboratory research applications and are not intended for diagnostic or therapeutic use.

BNP Antibody (D-8) Specifications

Alternate Product Name: B Type Natriuretic Peptide

Product Clone Name: D-8

Classification: Primary Antibody

Clonality: Monoclonal Antibody

Antibody Isotype: IgM kappa light chain

Amino Acids: 94-115

Epitope Target: BNP

Epitope Species: human

Product Reactivity/Detection: precursor and mature γ-BNP, BNP 32 and natriuretic peptide

Species Reactivity/Detection: human

Additional Mammalian Reactivity: N/A

Additional Non-Mammalian Reactivity: N/A

Applications: WB, IP, IF, IHC(P), ELISA

Vialing Information: Each vial contains 200 µg IgM kappa light chain in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin

Research Citations: 31 citations in various scientific publications

Available Conjugates/Forms for BNP Antibody (D-8): P: Blocking Peptide